Trial Profile
A study assessing relationship between edoxaban equivalent concentration and concentration of M-4
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Apr 2018
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Adverse reactions; Pharmacokinetics
- 09 Apr 2018 New trial record